Pharmacological and Mechanical Support Approaches in the Management of Acute Heart Failure in the Regional Network Model for the Management of Cardiogenic Shock
The goal of this observational study is to understand and describe the epidemiology of cardiogenic shock in Emilia Romagna with a specific focus on outcome stratified by aetiologies, sex and age. The main outcomes are:
* Incidence of cardiogenic shock (CS) over the total CICU admissions, CS-related in-hospital mortality and length of hospitalization, stratified by aetiologies, sex and age
* Epidemiology of patients admitted with CS, regarding age, gender, etiology and modality of presentation (acute or acute on chronic), echocardiographic and haemodynamic data, treatment strategy with inotropes and/or short-term MCS, cardiac arrest.
This is an observational study without intervention. Patients will be treated according to current clinical practice, according to physician judgment and data sheets of each drug used according to clinical practice.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Adult patients (≥18 years old) admitted to a participating CICU with suspected CS of stage from C to E according to SCAI (Society of cardiovascular intervention)classification of cardiogenic shock.
* Signed informed consent.
Exclusion Criteria:
* CS following cardiac surgery (post-cardiotomy), ● Significant polytrauma or neurological injury.
Primary outcome measure(s)
Incidence of CS over the total CICU admissions stratified by aetiologies, sex and age. — 5 years Incidence
Length of hospitalization, stratified by aetiologies, sex and age. — 5 years Days
CS-related in-hospital mortality stratified by aetiologies, sex and age. — 5 years Incidence
Epidemiology of patients admitted with CS, regarding age, gender, etiology and modality of presentation (acute or acute on chronic), echocardiographic and haemodynamic data, treatment strategy with inotropes and/or short-term MCS, cardiac arrest. — 5 years Demography description
Recovery from cardiogenic shock, defined as improvement to at least SCAI stage B or discharge from CICU to a step-down ward — 5 years Recovery from cardiogenic shock
In-hospital survival according to age, etiology, presentation (acute or acute on chronic) and modality of treatment (inotropes or MCS). — 5 years In-hospital survival
Rate and reason of unplanned re-hospitalizations within one month after primary discharge — 5 years Rate and reason of unplanned re-hospitalizations
Workload burden will be estimated as the percentage of CS admission and the mean duration of CICU stay as compared to other admissions during study period — 5 years Workload burden
Rate of adherence to several items and differences between older era (retrospective data) and prospective cohort — 5 years Blood counts, ECG, oxygen saturation and respiratory monitoring.
Trial sites (1)
Facility
City
Region
Status
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna
Bologna
Recruiting
More IRCCS Azienda Ospedaliero-Universitaria di Bologna trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.